Our portfolio has been enriched with a new product: Eudiamet 40:1.
Wrong habits and bad nutrition affect our health more then we can imagine. The current data show that people all over the world are increasingly weak and at high risk to develop diseases.
The Lo.Li.Pharma research responded to this issue developing a new innovative and complete formulation, that becomes a new tool to facilitate physicians in their commitment to preserving people’s health.
Share the Post:
Related Posts
Role of myo-inositol in postmenopausal metabolic syndrome
Metabolic syndrome in postmenopausal women represents a major challenge in women’s health, with increasing clinical and socio-economic implications. Increased life
HOMA-IR: measuring insulin resistance to assess metabolic risk
Insulin resistance is widely recognized as a key pathophysiological determinant of metabolic syndrome, type 2 diabetes, and cardiovascular disease. Epidemiological